Lok Sabha Question No. 5829 (UNSTARRED), answered on 2018-04-03
Subject: PSUs in UPI
Ministry: CHEMICALS AND FERTILIZERS
Asked by: A.T. (NANA) PATIL, SANTOSH AHLAWAT

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION NO. 5829 TO BE ANSWERED ON THE 03 rd  April, 2018

## PSUs in UPI

## 5829. SHRI A.T. NANA PATIL:

SHRIMATI SANTOSH AHLAWAT:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a)  whether  it  is  true  that  the  share  of  Public  Sector  Undertakings  (PSUs)  in Universal Immunization Programme (UIP) had been miniscule or nil during the last three years;
- (b)  if so, the details thereof and the reasons therefor; and
- (c)  the fresh steps taken by the Government to boost home production of vaccines by  the  PSUs  to  ensure  uninterrupted  supply  of  vaccines  for  UIP  as  well  as  to ensure health security of the country?

## ANSWER

## MINISTER  OF  STATE  FOR  MINISTRY  OF  CHEMICALS  AND  FERTILIZERS,  ROAD TRANSPORT & HIGHWAYS AND SHIPPING (SHRI MANSUKH L. MANDAVIYA)

(a)  to  (b)  No,  madam.  The  Government  is  not  exclusively  dependent  on  the  private sector  for  the  vaccines  produced  by  Public  Sector  Undertakings  (PSUs).  However, substantial requirement of remaining vaccines under Universal Immunization Programme (UIP) is being met through the private sector. The status of production & supply  of  the  vaccine  manufactured  by  the  Public  Sector  Vaccine  Manufacturing Institutes during the last three years is as under:

| Name of Product   | 2014-15    | 2014-15   | 2015-16    | 2015-16   | 2016-17    | 2016-17   |
|-------------------|------------|-----------|------------|-----------|------------|-----------|
| Name of Product   | Production | Supply    | Production | Supply    | Production | Supply    |
| DPT (Lakh Doses)  | 64.91      | 17.52     | 52.86      | 66.00     | --         | 34.09     |
| TT (Lakh Doses)   | 46.68      | 34.50     | 76.98      | 42.00     | 64.71      | 76.00     |

(c): The Government has approved projects of the following Public Sector Vaccine Manufacturing Units for up-gradation with increase in annual installed capacity:

- (i) Central Research Institute (CRI), Kasauli;
- (ii) BCG VL, Guindy; and
- (iii) Pasteur Institute of India (PII), Coonoor.

CRI,  Kasauli  has  already  started  functioning  after  up-gradation.  BCG  VL  Guindy  has also  produced  the  consistency  batches  of  BCG  Vaccine  and  its  quality  testing  is underway. After clearing the testing protocols, BCG VL, Guindy will supply 45-50 lakh doses  of  BCG  Vaccines  per  month  from  August,  2018  onwards.  The  up-gradation project  of  PII,  Coonoor  is  nearing  completion  and  the  production  of  trial  batches  will commence by August, 2018.

In  addition,  the  Government  has  also  approved  establishment  of  Project  of  National Importance, namely Integrated Vaccine Complex (IVC) as a subsidiary of HLL Life Care Ltd.  with  a  cost  of  Rs.594  Crores.  On  completion  of  the  project,  IVC  would  produce Pentavalent  Vaccine  BCG,  Measles,  Hepatitis  B  Human  Rabies  and  Japanese Encephalitis Vaccines. As per policy decision, CRI, Kasauli and PII, Coonoor will supply 75%  of  Bulk  Production  of  DPT  components  to  IVC  for  production  of  Pentavalent Vaccine.  After  utilization  of  full  capacity  of  the  Public  Sector  Vaccine  Manufacturing Institutes, the dependency on private manufacturing units will be reduced considerably.

*****